Cargando…

Treatment of Infected Hip Arthroplasty

The clinical outcomes of a consecutive series of deep total joint infections treated with a prosthesis retaining protocol were reviewed. The treatment of deep periprosthetic joint infections is challenging. In recent years, two-stage exchange arthroplasty has emerged as the gold standard for success...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernigou, Philippe, Flouzat-Lachianette, C.-H., Jalil, R., Uirassu Batista, Sobrinho, Guissou, I., Poignard, A.
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864510/
https://www.ncbi.nlm.nih.gov/pubmed/20448834
http://dx.doi.org/10.2174/1874325001004010126
_version_ 1782180784155656192
author Hernigou, Philippe
Flouzat-Lachianette, C.-H.
Jalil, R.
Uirassu Batista, Sobrinho
Guissou, I.
Poignard, A.
author_facet Hernigou, Philippe
Flouzat-Lachianette, C.-H.
Jalil, R.
Uirassu Batista, Sobrinho
Guissou, I.
Poignard, A.
author_sort Hernigou, Philippe
collection PubMed
description The clinical outcomes of a consecutive series of deep total joint infections treated with a prosthesis retaining protocol were reviewed. The treatment of deep periprosthetic joint infections is challenging. In recent years, two-stage exchange arthroplasty has emerged as the gold standard for successful elimination of infection. With success rates averaging 82% to 96%, this treatment method has both the highest and most consistent rate of infection eradication. Another alternative in the treatment of the deep periprosthetic infection is the single-stage exchange arthroplasty. Successful eradication of infection after single-stage exchange arthroplasty has been reported to average from 60% to 83% after total hip infections. While both the single and two-stage exchange arthroplasty are viable treatment options, they are associated with negative factors such as they are time consuming, expensive, and may entail a 6- to 12-week period with a minimally functioning extremity after prosthesis removal. This paper reports the general principles of management, the treatment of acute infection occurring in the postoperative period or later, and the treatment of chronic infection by exchange arthroplasty or resection arthroplasty.
format Text
id pubmed-2864510
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-28645102010-05-06 Treatment of Infected Hip Arthroplasty Hernigou, Philippe Flouzat-Lachianette, C.-H. Jalil, R. Uirassu Batista, Sobrinho Guissou, I. Poignard, A. Open Orthop J Article The clinical outcomes of a consecutive series of deep total joint infections treated with a prosthesis retaining protocol were reviewed. The treatment of deep periprosthetic joint infections is challenging. In recent years, two-stage exchange arthroplasty has emerged as the gold standard for successful elimination of infection. With success rates averaging 82% to 96%, this treatment method has both the highest and most consistent rate of infection eradication. Another alternative in the treatment of the deep periprosthetic infection is the single-stage exchange arthroplasty. Successful eradication of infection after single-stage exchange arthroplasty has been reported to average from 60% to 83% after total hip infections. While both the single and two-stage exchange arthroplasty are viable treatment options, they are associated with negative factors such as they are time consuming, expensive, and may entail a 6- to 12-week period with a minimally functioning extremity after prosthesis removal. This paper reports the general principles of management, the treatment of acute infection occurring in the postoperative period or later, and the treatment of chronic infection by exchange arthroplasty or resection arthroplasty. Bentham Open 2010-03-02 /pmc/articles/PMC2864510/ /pubmed/20448834 http://dx.doi.org/10.2174/1874325001004010126 Text en © Hernigou et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Hernigou, Philippe
Flouzat-Lachianette, C.-H.
Jalil, R.
Uirassu Batista, Sobrinho
Guissou, I.
Poignard, A.
Treatment of Infected Hip Arthroplasty
title Treatment of Infected Hip Arthroplasty
title_full Treatment of Infected Hip Arthroplasty
title_fullStr Treatment of Infected Hip Arthroplasty
title_full_unstemmed Treatment of Infected Hip Arthroplasty
title_short Treatment of Infected Hip Arthroplasty
title_sort treatment of infected hip arthroplasty
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864510/
https://www.ncbi.nlm.nih.gov/pubmed/20448834
http://dx.doi.org/10.2174/1874325001004010126
work_keys_str_mv AT hernigouphilippe treatmentofinfectedhiparthroplasty
AT flouzatlachianettech treatmentofinfectedhiparthroplasty
AT jalilr treatmentofinfectedhiparthroplasty
AT uirassubatistasobrinho treatmentofinfectedhiparthroplasty
AT guissoui treatmentofinfectedhiparthroplasty
AT poignarda treatmentofinfectedhiparthroplasty